Literature DB >> 8475256

On the equivalent dose for Auger electron emitters.

R W Howell1, V R Narra, K S Sastry, D V Rao.   

Abstract

Radionuclides that emit Auger electrons are widely used in nuclear medicine (e.g., 99mTc, 123I, 201Tl) and biomedical research (e.g., 51Cr, 125I), and they are present in the environment (e.g., 40K, 55Fe). Depending on the subcellular distribution of the radionuclide, the biological effects caused by tissue-incorporated Auger emitters can be as severe as those from high-LET alpha particles. However, the recently adopted recommendations of the International Commission on Radiological Protection (ICRP) provide no guidance with regard to calculating the equivalent dose for these radionuclides. The present work, using spermatogenesis in mouse testis as the experimental model, shows that the lethality of the prolific Auger emitter 125I is linearly dependent on the fraction of the radioactivity in the organ that is bound to DNA. This suggests that the equivalent dose for Auger emitters may have a similar linear dependence. Accordingly, a formalism for calculating the equivalent dose for Auger emitters is advanced within the ICRP framework.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475256      PMCID: PMC3690377     

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  39 in total

1.  In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles.

Authors:  D V Rao; V R Narra; R W Howell; G F Govelitz; K S Sastry
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

2.  Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells.

Authors:  A I Kassis; S J Adelstein; C Haydock; K S Sastry; K D McElvany; M J Welch
Journal:  Radiat Res       Date:  1982-05       Impact factor: 2.841

3.  Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo.

Authors:  D V Rao; V R Narra; R W Howell; K S Sastry
Journal:  Radiat Res       Date:  1990-11       Impact factor: 2.841

4.  Radiation damage to mouse testis cells from [99mTc] pertechnetate.

Authors:  T A Mian; N Suzuki; H J Glenn; T P Haynie; M L Meistrich
Journal:  J Nucl Med       Date:  1977-11       Impact factor: 10.057

5.  Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells.

Authors:  A I Kassis; F Fayad; B M Kinsey; K S Sastry; S J Adelstein
Journal:  Radiat Res       Date:  1989-05       Impact factor: 2.841

6.  Malignant transformation induced by incorporated radionuclides in BALB/3T3 mouse embryo fibroblasts.

Authors:  P K LeMotte; S J Adelstein; J B Little
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.

Authors:  V R Narra; R W Howell; R S Harapanhalli; K S Sastry; D V Rao
Journal:  J Nucl Med       Date:  1992-12       Impact factor: 10.057

8.  Reduction in sperm levels after testicular irradiation of the mouse: a comparison with man.

Authors:  M L Meistrich; R C Samuels
Journal:  Radiat Res       Date:  1985-04       Impact factor: 2.841

9.  Role of mitochondrial DNA in cell death induced by 125I decay.

Authors:  L S Yasui; K G Hofer
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1986-04

10.  Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.

Authors:  K D Bagshawe; K Sharma; P J Southall; J A Boden; G M Boxer; T A Patridge; P Antoniw; R B Pedley
Journal:  Br J Radiol       Date:  1991-01       Impact factor: 3.039

View more
  14 in total

1.  Cytotoxicity, genotoxicity and intracellular distribution of the Auger electron emitter (65)Zn in two human cell lines.

Authors:  Ralf Kriehuber; Manuela Riedling; Myrtill Simkó; Dieter G Weiss
Journal:  Radiat Environ Biophys       Date:  2004-04-23       Impact factor: 1.925

Review 2.  Internal dosimetry: developments and limitations.

Authors:  P J Mountford
Journal:  Eur J Nucl Med       Date:  1996-05

3.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

Review 4.  Auger radiation targeted into DNA: a therapy perspective.

Authors:  Franz Buchegger; Florence Perillo-Adamer; Yves M Dupertuis; Angelika Bischof Delaloye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-08       Impact factor: 9.236

5.  Relative biological effectiveness of alpha-particle emitters in vivo at low doses.

Authors:  R W Howell; M T Azure; V R Narra; D V Rao
Journal:  Radiat Res       Date:  1994-03       Impact factor: 2.841

6.  Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo.

Authors:  R W Howell; S M Goddu; V R Narra; D R Fisher; R E Schenter; D V Rao
Journal:  Radiat Res       Date:  1997-03       Impact factor: 2.841

7.  Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.

Authors:  K J Kairemo; H A Ramsay; M Tagesson; A P Jekunen; T K Paavonen; H A Jääskelä-Saari; K Liewendahl; K Ljunggren; S Savolainen; S E Strand
Journal:  Eur J Nucl Med       Date:  1996-06

8.  Targeted Brain Tumor Radiotherapy Using an Auger Emitter.

Authors:  Giacomo Pirovano; Stephen A Jannetti; Lukas M Carter; Ahmad Sadique; Susanne Kossatz; Navjot Guru; Paula Demétrio De Souza França; Masatomo Maeda; Brian M Zeglis; Jason S Lewis; John L Humm; Thomas Reiner
Journal:  Clin Cancer Res       Date:  2020-02-17       Impact factor: 12.531

9.  Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy.

Authors:  Elise Verger; Jordan Cheng; Vittorio de Santis; Madeleine Iafrate; Jessica A Jackson; Cinzia Imberti; Gilbert O Fruhwirth; Philip J Blower; Michelle T Ma; Daniel R Burnham; Samantha Y A Terry
Journal:  Nucl Med Biol       Date:  2021-06-15       Impact factor: 2.408

10.  Tumor burden talks in cancer treatment with PEGylated liposomal drugs.

Authors:  Yi-Yu Lin; Hao-Wen Kao; Jia-Je Li; Jeng-Jong Hwang; Yun-Long Tseng; Wuu-Jyh Lin; Ming-Hsien Lin; Gann Ting; Hsin-Ell Wang
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.